Pharmacia and Upjohn merge

Latest move in global shake-up creates pounds 4.5bn drugs group

NIGEL COPE

The consolidation of the world's pharmaceuticals industry took another leap forward yesterday when Pharmacia of Sweden and Upjohn of the United States announced they were to merge.

The combined group, which will be known as Pharmacia and Upjohn, will become one of the world's largest pharmaceuticals companies, with a turnover of about SKr50bn (pounds 4.5bn).

Shares in both companies had risen sharply in New York and Stockholm on Friday amid increasing speculation that a deal was imminent.

Announcing the merger at a news conference in Stockholm yesterday afternoon, the two companies seemed to signal further acquisitions when they said the merged group would be one of the most debt-free companies in the industry and therefore able to take advantage of further growth opportunities.

The combined corporate headquarters will be based in London and will have listings on the Stock Exchange in London, New York and Stockholm. The merger, which is on a 50-50 basis, is expected to be completed by November.

The announcement comes just two days after Rhone-Poulenc Rorer, the US drugs subsidiary of the French chemicals group Rhone-Poulenc, launched a pounds 1.7bn hostile bid for Fisons, the UK pharmaceuticals group. Fisons has rejected the offer and will this week step up the search for a rescue bidder. So far the list of potential white knights includes Glaxo-Wellcome, Zeneca, Astra of Sweden and Schering-Plough of the United States.

A spokesman for Fisons said yesterday that "several parties have already been on the phone", but that no discussions about possible rescue bids were yet scheduled to take place.

The Pharmacia-Upjohn merger brings together two powerful groups of roughly equal size. Pharmacia is a niche drugs group specialising in drugs for growth hormones, cataract surgery and smoking. It made profits of SKr5.32bn (pounds 475m) last year on sales of SKr26.5bn (pounds 2.4bn). It was privatised last year and has said it was keen to enhance its position in the US.

Upjohn's portfolio include Halcion sleeping tablets, Rogaine baldness treatment and a new anti-impotence drug called Caverject.

However, profits fell to $489m (pounds 326m) last year on sales which were down to $3.3bn (pounds 2.2bn) after the loss of important drugs patents. Four of its top drugs, generating sales of $1bn (pounds 666m) between them, have lost US patent protection in the last three years.

Rogaine was refused a licence by the American Food and Drug Administration, and Freedox, which is a treatment to help stroke and head injury victims recover, had its trials halted after safety problems.

These delays left Upjohn with a large hole in its development pipeline which may have prompted the Upjohn family, which still holds a significant stake in the company, to seek a merger.

Pharmacia said that its two main shareholders, Volvo, the car manufacturer, and the Swedish state, have both given the go ahead for the merger. Volvo has been keen to sell its stake in Pharmacia as part of a disposal programme of non-core businesses.

Volvo will exchange its 27.5 per cent stake in Pharmacia for a 13.8 per scent holding in the enlarged group. Shareholders in Upjohn will receive 1.45 new shares for every existing share.

There will also be significant scope for cost-cutting. The two companies estimate that the merger could save Skr3.5bn (pounds 312m) in costs. However, expenditure on research and development would still exceed SKr7bn (pounds 636m).

The deal is the latest in a flurry of take-overs and mergers in the world's pharmaceuticals market, which is still seen as a fragmented industry. Rhone Poulenc's pounds 1.7bn bid for Fisons may go through if no rescue bidder can be found.

Glaxo absorbed Wellcome in a pounds 9bn deal in January that created the world's largest drugs company. Zeneca, the UK drugs group, has been cited as both a potential bidder and bid target.

Start your day with The Independent, sign up for daily news emails
Life and Style
healthMeet the volunteer users helping to see if the banned drug can help cure depression and addiction
Arts and Entertainment
tvDick Clement and Ian La Frenais are back for the first time in a decade
Life and Style
tech
News
i100
News
Foo Fighters lead man Dave Grohl talks about the band's forthcoming HBO documentary series
people
News
i100
News
ebooksAn unforgettable anthology of contemporary reportage
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Guru Careers: Pricing Analyst

£30 - 35k: Guru Careers: We are seeking a Pricing Analyst to join a leading e-...

SThree: Trainee Recruitment Consultant

£20000 - £25000 per annum + OTE £45K YR1: SThree: At SThree, we like to be dif...

SThree: Trainee Recruitment Consultant

£20000 - £25000 per annum + competitive: SThree: Did you know? SThree is a mul...

Guru Careers: C# Project Team Lead

£55 - 65k (DOE): Guru Careers: A unique opportunity for a permanent C# Develop...

Day In a Page

Thousands of teenage girls enduring debilitating illnesses after routine school cancer vaccination

Health fears over school cancer jab

Shock new Freedom of Information figures show how thousands of girls have suffered serious symptoms after routine HPV injection
Fifa President Sepp Blatter warns his opponents: 'I forgive everyone, but I don't forget'

'I forgive everyone, but I don't forget'

Fifa president Sepp Blatter issues defiant warning to opponents
Extreme summer temperatures will soon cause deaths of up to 1,700 more Britons a year, says government report

Weather warning

Extreme summer temperatures will soon cause deaths of up to 1,700 more Britons a year, says government report
LSD: Speaking to volunteer users of the drug as trials get underway to see if it cures depression and addiction

High hopes for LSD

Meet the volunteer users helping to see if it cures depression and addiction
Why the cost of parenting has become so expensive

Why the cost of parenting has become so expensive

Today's pre-school child costs £35,000, according to Aviva. And that's but the tip of an iceberg, says DJ Taylor
Fifa corruption: The officials are caught in the web of US legal imperialism - where double standards don't get in the way

Caught in the web of legal imperialism

The Fifa officials ensnared by America's extraterritorial authority are only the latest examples of this fearsome power, says Rupert Cornwell
Bruce Robinson: Creator of Withnail and I on his new book about Jack the Ripper

'Jack the Ripper has accrued a heroic aura. But I'm going after the bastard'

The deaths of London prostitutes are commonly pinned on a toff in a top hat. But Bruce Robinson, creator of Withnail and I, has a new theory about the killer's identity
Simon Stephens interview: The playwright on red-blooded rehearsals, disappointing his children - and why plays are like turtles

Simon Stephens interview

The playwright on red-blooded rehearsals, disappointing his children - and why plays are like turtles
Holidaying with a bike nut: Cycling obsessive Rob Penn convinces his wife to saddle up

Holidaying with a bike nut

Cycling obsessive Rob Penn convinces his wife to saddle up
Bill Granger recipes: Our chef pays homage to South-east Asia's palate-refreshing desserts

Bill Granger's fruity Asian desserts

Our chef's refreshing desserts are a perfect ending to a spicy, soy-rich meal
Fifa presidential election: What is the best way to see off Sepp Blatter and end this farce?

Michael Calvin's Last Word

What is the best way to see off Sepp Blatter and end this farce?
Mediterranean migrant crisis: 'If Europe thinks bombing boats will stop smuggling, it will not. We will defend ourselves,' says Tripoli PM

Exclusive interview with Tripoli PM Khalifa al-Ghweil

'If Europe thinks bombing boats will stop smuggling, it will not. We will defend ourselves'
Raymond Chandler's Los Angeles: How the author foretold the Californian water crisis

Raymond Chandler's Los Angeles

How the author foretold the Californian water crisis
Chinese artist who posted funny image of President Xi Jinping facing five years in prison as authorities crackdown on dissent in the arts

Art attack

Chinese artist who posted funny image of President Xi Jinping facing five years in prison